000 | 01921 a2200565 4500 | ||
---|---|---|---|
005 | 20250516121033.0 | ||
264 | 0 | _c20130730 | |
008 | 201307s 0 0 eng d | ||
022 | _a1569-8041 | ||
024 | 7 |
_a10.1093/annonc/mds527 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _ade Haas, E C | |
245 | 0 | 0 |
_aEarly development of the metabolic syndrome after chemotherapy for testicular cancer. _h[electronic resource] |
260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _cMar 2013 |
||
300 |
_a749-55 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
650 | 0 | 4 |
_aCardiovascular Diseases _xchemically induced |
650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aKaplan-Meier Estimate |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMetabolic Syndrome _xchemically induced |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aOverweight _xchemically induced |
650 | 0 | 4 | _aPrevalence |
650 | 0 | 4 | _aROC Curve |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aTesticular Neoplasms _xdrug therapy |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aAltena, R | |
700 | 1 | _aBoezen, H M | |
700 | 1 | _aZwart, N | |
700 | 1 | _aSmit, A J | |
700 | 1 | _aBakker, S J L | |
700 | 1 | _avan Roon, A M | |
700 | 1 | _aPostma, A | |
700 | 1 | _aWolffenbuttel, B H R | |
700 | 1 | _aHoekstra, H J | |
700 | 1 | _avan Leeuwen, F E | |
700 | 1 | _aSleijfer, D T | |
700 | 1 | _aGietema, J A | |
773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 24 _gno. 3 _gp. 749-55 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/annonc/mds527 _zAvailable from publisher's website |
999 |
_c22244403 _d22244403 |